VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

Therapy Areas

Ophthalmology

Strategic statistical consulting for vision-critical devices

Overview

BSC provides statistical expertise for ophthalmic devices and therapeutics, including intraocular lenses (IOLs), refractive surgery systems, glaucoma treatments, and retinal disease management technologies. Our experience spans both surgical and diagnostic ophthalmology devices.

Specialized Capabilities

Visual acuity endpoint design (ETDRS, logMAR). Handling of inter-eye correlation in bilateral studies. Non-inferiority margin justification for ophthalmic devices. Intraocular pressure modeling for glaucoma devices. Retinal imaging endpoint assessment.

Regulatory Experience

We understand ophthalmology division expectations for vision endpoint assessment, including appropriate vision testing protocols, handling of fellow-eye effects, and long-term safety monitoring for implantable devices. Our team has successfully navigated discussions around appropriate comparators and study designs.

Representative Studies

  • Intraocular lenses, IOLS, (monofocal, multifocal, toric)

  • Glaucoma drainage devices and minimally invasive procedures

  • Laser refractive surgery systems

  • Retinal treatment devices and drug delivery systems

  • Ophthalmic diagnostic imaging devices

Design

We use innovative approaches Bayesian design, adaptive clinical trial design, and Propensity Score Matching to reduce costs, overcome limited data access, and minimize bias in non-randomized studies.

Analyze

Advance

Testimonials

See what our sponsors say about BSC®

On Experience

“Battle ground tested.”

“There is nothing that David and team haven’t seen over the years – the good, bad, and ugly.”

• Vice President, Clinical Operations

• Former FDA Regulator

• CEO, Medical Device Company

Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.